Emily Menendez

DocwireNews

Barrett’s esophagus (BE) occurs due to chronic acid reflux, and the risk of developing esophageal cancer is between 30 and 125 times higher in patients with the condition.
Endoscopic eradication therapy (EET) can be used to effectively eradicate BE and related conditions, but it has a greater risk of harm and requires more resources than surveillance endoscopy.
A <a href="https://www.gastrojournal.org/article/S0016-5085(24)00302-0/fulltext" target="_blank" rel="noopener">clinical practice guideline released by the American Gastroenterological Association (AGA)</a> contains new recommendations for clinicians and patients regarding EET for BE and related neoplasia.
Researchers used the Grading of Recommendations Assessment, Development, and Evaluation framework to assess evidence. They used the Evidence-to-Decision Framework to develop recommendations regarding EET in patients with BE under the following scenarios.
Presence of high-grade dysplasia
A strong recommendation for EET in patients with high-grade dysplasia was made based on moderate certainty of evidence. After EET, regular surveillance should be conducted to monitor any recurrence or new developments.
Presence of low-grade dysplasia
Low-grade dysplasia carries a lower risk of progression, so a conditional recommendation was made in favor of EET. Patients who place a higher value on the potential harms and a lower value on the benefits (which are uncertain) regarding the reduction of esophageal cancer mortality could reasonably select surveillance endoscopy. Surveillance intervals should be adjusted after EET based on initial findings.
No dysplasia
As cells in nondysplastic BE are abnormal, they do not show dysplasia, leading to a recommendation against the use of EET due to low evidence regarding its effects in this patient group.
Choice of stepwise endoscopic mucosal resection (EMR) or focal EMR plus ablation
Based on a patient’s lesion characteristics, a conditional recommendation was made in favor of focal EMR plus ablation over stepwise EMR. Radiofrequency ablation is the preferred procedure for ablating remaining segments.
Endoscopic submucosal dissection (ESD) versus EMR
In patients with visible neoplastic lesions undergoing resection, the use of either EMR or ESD is suggested based on lesion characteristics. While EMR is typically suitable for most cases, ESD may be considered for more complex lesions.
Providers should engage in shared decision-making based on patient preferences.

Brandon Twyford

BREAKWATER Trial: Encorafenib Plus Cetuximab With FOLFIRI Shows Strong Efficacy in BRAF V600E-mutant mCRC

Colorectal Cancer

T-DXd with Fluoropyrimidine and Pembrolizumab Shows Strong Antitumor Activity in Advanced HER2+ Gastric, Esophageal Cancers

Gastric Cancer

Zachary Bessette

CABINET: Updated PFS, Subgroup Analyses of Cabozantinib Versus Placebo for Advanced NET

GEP-NETs

Latest News

New AGA Guideline Focuses on EET for Barrett's Esophagus

Gastroesophageal Cancer

Barrett’s esophagus occurs due to chronic acid reflux, and the risk of developing esophageal cancer is between 30 and 125 times higher in patients with the condition.

New AGA Guideline Focuses on EET for Barrett Esophagus

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Career Center

Expert Interviews

Subscribe